Theoretical Discussion on the Treatment of Cough Variant Asthma by Harmonizing Yingqi and Weiqi

Abstract

Abstract: Cough variant asthma accounts for up to 1/3 of all chronic cough causes.In this article，we explored the relationships of disharmony of Yingqi and Weiqi with TCM-based physical characteristics，and pathogenesis of allergic reactions caused by immune imbalance at remission stage of cough variant asthma，and TCM-related etiologic factors and morbidity characteristics at the exacerbation stage.And we concluded that the basic pathogenesis of cough variant asthma is disharmony between Yingqi and Weiqi，so harmonizing the relationship between the two is an important therapeutic method for the disease.Finally we expounded the application ways of Guizhi decoction，a treatment regimen，which can be modified in accordance with the individual conditions at both remission and exacerbation stages.

Key words: Asthma, Cough, Ying-wei disharmony, Guizhi decoction, Ying-wei therapeutic methods

摘要： 咳嗽变异性哮喘占临床所有慢性咳嗽病因的1/3以上，本文分别从咳嗽变异性哮喘缓解期的中医体质特点、免疫失衡所致的变态反应发病机制和发作期的中医学病因、发病等特点与营卫不和的关系进行了探究，并归纳认为营卫不和是咳嗽变异性哮喘的基本病机，得出了调和营卫法是治疗咳嗽变异性哮喘的重要方法，进而阐述了桂枝汤类方在咳嗽变异性哮喘缓解期和急性期的加减运用方法。

关键词: 哮喘, 咳嗽, 营卫不和, 桂枝汤, 营卫治法

WANG Quanlin,WANG Fei. Theoretical Discussion on the Treatment of Cough Variant Asthma by Harmonizing Yingqi and Weiqi　[J]. Chinese General Practice, 2019, 22(30): 3722-3725.
王全林,王飞. 调和营卫法治疗咳嗽变异性哮喘的理论探讨[J]. 中国全科医学, 2019, 22(30): 3722-3725.

References

［1］中华医学会呼吸病学分会哮喘学组.咳嗽的诊断与治疗指南（2015）［J］.中华结核和呼吸杂志，2016，39（5）：323-354.DOI：10.3760/cma.j.issn.1001-0939.2016.05.003.
［2］LAI K F，CHEN R C，LIN J T，et al.A prospective，multicenter survey on causes of chronic cough in China［J］.Chest，2013，143（3）：613-620.DOI：10.1378/chest.12-0441.
［3］中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南（2016年版）［J］.中华结核和呼吸杂志，2016，39（9）：675-697.DOI：10.3760/cma.j.issn.1001-0939.2016.09.007.
［4］SINGH S，LOKE Y K.An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease［J］.Int J Chron Obstruct Pulmon Dis，2010，5：189-195.
［5］罗社文，李金宪，韩春生，等.咳嗽变异性哮喘的中医药研究近况［J］.中医杂志，2003，44（1）：69-71.DOI：10.3321/j.issn：1001-1668.2003.01.042.
LUO S W，LI J X，HAN C S，et al.Resent development in TCM studies on cough variability asthma［J］.Journal of Traditional Chinese Medicine，2003，44（1）：69-71.DOI：10.3321/j.issn：1001-1668.2003.01.042.
［6］冯淬灵，武维屏.武维屏教授治疗咳嗽变异性哮喘经验［J］.北京中医药大学学报，2009，32（8）：574-576.DOI：10.3321/j.issn：1006-2157.2009.08.018.
FENG C L，WU W P.Professor WU Wei-ping's experience on curing cough variant asthma［J］.Journal of Beijing University of Traditional Chinese Medicine，2009，32（8）：574-576.DOI：10.3321/j.issn：1006-2157.2009.08.018.
［7］吴继全，陈燕，晁恩祥.晁恩祥治疗咳嗽变异型哮喘经验［J］.北京中医，2006，25（11）：657-658.DOI：10.3969/j.issn.1674-1307.2006.11.007.
WU J Q，CHEN Y，CHAO E X.Doctor CHAO Enxiang's experience on treatment of variant asthma of cough［J］.Beijing Journal of Traditional Chinese Medicine，2006，25（11）：657-658.DOI：10.3969/j.issn.1674-1307.2006.11.007.
［8］陈瑞，王鹏.浅谈肺痹与特发性肺纤维化的关系［J］.中国中医药信息杂志，2005，12（6）：90-91.DOI：10.3969/j.issn.1005-5304.2005.06.060.
［9］王永炎，沈绍功.今日中医内科-上卷［M］.北京：人民卫生出版社，2000：309.
［10］杨淦，张先元，曹栀，等.特发性肺纤维化与肺痹、肺萎关系浅析［J］.亚太传统医药，2015，11（2）：52-53.DOI：10.11954/ytctyy.201502019.
［11］叶家荣.咳嗽变异性哮喘发病因素与体质特点相关性研究［D］.广州：广州中医药大学，2015.
［12］张庆祥.过敏性肺病与体质类型关系的初步探讨［C］//中华中医药学会.第十三次中医体质学术年会暨中医体质理论与健康服务技能培训班论文集.昆明：中华中医药学会中医体质分会，云南中医学院，云南中医学院第一附属医院，2015：221-224.
［13］唐诗，刘夏曦，张新渝.论《灵枢》卫气的运行［C］//中华中医药学会.第十二届全国内经学术研讨会学术论文集.成都：中华中医药学会内经学分会，成都中医药大学，2012：45-46.
［14］黄煌.中医十大类方［M］.南京：江苏科学技术出版社，2010.
［15］张剑勇.李志铬教授论中医与免疫［J］.世界中西医结合杂志，2009，4（10）：696-697.DOI：10.3969/j.issn.1673-6613.2009.10.005.
［16］曹维宏.咳嗽变异性哮喘中医病因病机研究进展［J］.陕西中医，2011，32（12）：1685-1686.DOI：10.3969/j.issn.1000-7369.2011.12.071.
［17］苗青，丛小东，苗倩倩，等.咳嗽变异性哮喘从“微寒微咳”论治［J］.新中医，2012，44（10）：5-7.DOI：10.13457/j.cnki.jncm.2012.10.031.
［18］黄煌.黄煌经方使用手册［M］.北京：中国中医药出版社，2010：38-44.
［19］杜文燮.明清中医临证小丛书——药鉴［M］.北京：中国中医药出版社，1993.
［20］陈潮祖.中医治法与方剂［M］.北京：人民卫生出版社，2009.

[1]	LIANG Xuan, NA Feiyang, QIN Mengyao, YANG Hui, GUO Li, GUO Qi, REN Lei, CHEN De, LIU Donghai, ZHANG Rongfang. Clinical Characteristics and Influencing Factors of Bronchial Asthma Combined with Obstructive Sleep Apnea-hypopnea Syndrome in Children [J]. Chinese General Practice, 2023, 26(33): 4225-4230.
[2]	LI Jingbo, PANG Gaofeng, REN Yanling, SHA Xixue, NI Huiping. Executive Function of GO/NOGO Paradigm Experiment in Children with Bronchial Asthma and Its Relationship with Pulmonary Function [J]. Chinese General Practice, 2023, 26(20): 2503-2507.
[3]	HU Xiaofeng, CAI Guangyun, XIAO Kun, XU Pusheng, YU Chunhong, LIN Haihuan. Effects of Exposure to Environmental Factors on Exhaled Nitric Oxide Levels in Patients with Non-acute Exacerbation of Bronchial Asthma [J]. Chinese General Practice, 2023, 26(09): 1086-1091.
[4]	SUN Rui, PAN Yi, TAN Aihua, WANG Jianxin, WANG Xuan, ZHANG Lijing. Hypertension with Bronchial Asthma: Interaction Mechanism and Management [J]. Chinese General Practice, 2023, 26(03): 274-279.
[5]	Shenzhen Group of Integrated Medical and Preventive Medicine Program for Respiratory Diseases, Shenzhen Center for the Prevention and Treatment of Major Respiratory Diseases, Shenzhen Community Health Association. Early Screening and Standardized Management Pathway for Bronchial Asthma in Shenzhen Community Healthcare Settings (Trial Version) [J]. Chinese General Practice, 2023, 26(03): 262-267.
[6]	WANG Jun, ZHANG Dong, FENG Zhenzhen, ZHANG Shujuan, ZHAO Guixiang, ZHANG Hailong, LI Jiansheng. Literature-based Research on Common Syndromes of Cough Variant Asthma [J]. Chinese General Practice, 2023, 26(03): 321-328.
[7]	CHANG Chun, SUN Yongchang. Global Strategy for Asthma Management and Prevention: Interpretation of the Updates in 2022 [J]. Chinese General Practice, 2022, 25(35): 4355-4362.
[8]	YANG Jiang, WANG Minghang, LI Jiansheng, LIN Xiaohong, LIU Yuanyuan, XIE Yang, LI Suyun. Risk Prediction Questionnaire and Item Screening for Acute Exacerbation of Asthma Based on the Modified Delphi Technique [J]. Chinese General Practice, 2022, 25(35): 4425-4432.
[9]	Weihong HAN, Huanhuan ZHAO, Xinmin TU, Minghang WANG. Inflammatory Phenotypes and Associated Factors in Bronchial Asthma Patients: a Cross-sectional Survey [J]. Chinese General Practice, 2022, 25(24): 2984-2991.
[10]	Zelin CHEN, Rui JIAO, Siyu WU, Zheng WANG, Guangwei ZHOU, Jing LI, Xinxiu LIU, Aihong MENG. Comparison of Clinical Characteristics and Response to Glucocorticoid Therapy in Patients with Different Inflammatory Phenotypes of AECOPD and ACO [J]. Chinese General Practice, 2022, 25(14): 1730-1735.
[11]	Jiang YANG, Xinmin TU, Huanhuan ZHAO, Xiaohong LIN, Yang XIE, Suyun LI, Minghang WANG. A Comparative Study of Levels of Serum Biomarkers in Patients with Different Stages of Asthma [J]. Chinese General Practice, 2022, 25(14): 1700-1706.
[12]	YU Xinxin, ZHENG Jinping, GAO Yi, XIE Yanqing, AN Jiaying, LIU Wenting, ZHONG Liping, WU Zhongping, ZHU Zheng. Iurnal Variability of Airway Hyperresponsiveness in Asthma Patients [J]. Chinese General Practice, 2022, 25(11): 1351-1356.
[13]	HUO Hongmin, YANG Yaofang, DONG Jiatian, MAO Zixian, HU Ping, SONG Fengchun. Development of a Personalized Pharmacologic Treatment Repository for Bronchial Asthma Based on the 2018 Guideline for the Diagnosis and Management of Bronchial Asthma in Primary Care（Practice Edition） [J]. Chinese General Practice, 2022, 25(10): 1181-1185.
[14]	WU Ruijian, HUANG Yuge, LUO Lianxiang. Metabolomics in Childhood Asthma [J]. Chinese General Practice, 2022, 25(08): 1014-1020.
[15]	CUI Tianyi, LIU Jiarui, LYU Bin, GAO Xiumei, ZHAO Xin. Novel Developments in the Relationship of Gut Microbiota and Immune Regulation with Childhood Asthma [J]. Chinese General Practice, 2022, 25(08): 1021-1026.